inspirator schreef op 9 juli 2014 08:12:
Introduktie Ruconest in US
Salix vermarktet XIFAXAN® (Rifaximin) Tabletten von 200 mg and 550 mg, MOVIPREP® (PEG 3350, sodium sulfat, sodium chloride, potassium chloride, sodium ascorbate and ascorbic Saure fuer oral Anwendung, 100 g/7.5 g/2.691 g/1.015 g/5.9 g/4.7 g), OSMOPREP® (sodium phosphate monobasic monohydrate, USP, und sodium phosphate dibasic anhydrous, USP) Tabletten, APRISO® (mesalamine) extended-release Kapseln 0.375 g, UCERIS® (budesonide) extended release tablets, für oralen Gebrauch, GIAZO® (balsalazide disodium) Tabletten, COLAZAL® (balsalazide disodium) Kapseln GLUMETZA® (metformin hydrochloride extended-release Tabletten) 500 mg and 1000 mg, ZEGERID® (omeprazole/sodium bicarbonate) Pulver für Orale Suspension, ZEGERID® (omeprazole/sodium bicarbonate) Kapsel, METOZOLV® ODT (metoclopramide hydrochloride), RELISTOR® (methylnaltrexone bromide) Subkutane Injektionen, FULYZAQ® (crofelemer) delayed-release Tabletten, SOLESTA®, DEFLUX®, PEPCID® (famotidine) für Orale Suspension, DIURIL® (chlorothiazide) Orale Suspension, AZASAN® (azathioprine) Tabletten, USP, 75/100 mg, ANUSOL-HC® 2.5% (Hydrocortisone Salbe, USP), ANUSOL-HC® 25 mg Zaepfchen(Hydrocortisone Acetate), PROCTOCORT® Salbe (Hydrocortisone Cream, USP) 1% und PROCTOCORT® Zäpfchen (Hydrocortisone Acetate Rectal Suppositories) 30 mg, CYCLOSET® (bromocriptine mesylate) Tabletten, FENOGLIDE® (fenofibrate) Tabletten. UCERIS (budesonide) Rektalschaum, RELISTOR®, LUMACAN', RUCONEST®, RHB-106 und Rifaximin für zusätzliche Indikationen sind in Entwicklung.
www.finanznachrichten.de/nachrichten-...